The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Drug Eluting Sinus Stent (DESS)-Global Market Insights and Sales Trends 2024

Drug Eluting Sinus Stent (DESS)-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1882153

No of Pages : 73

Synopsis
The global Drug Eluting Sinus Stent (DESS) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Drug Eluting Sinus Stent (DESS) in various end use industries. The expanding demands from the Hospital, Clinic and Other,, are propelling Drug Eluting Sinus Stent (DESS) market. Corticosteroid, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Silicon Resin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Eluting Sinus Stent (DESS), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Eluting Sinus Stent (DESS) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Eluting Sinus Stent (DESS) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Eluting Sinus Stent (DESS) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Eluting Sinus Stent (DESS) covered in this report include Intersect ENT,Inc., Medtronic Plc, Stryker Corporation and Johnson&Johnson, etc.
The global Drug Eluting Sinus Stent (DESS) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Intersect ENT,Inc.
Medtronic Plc
Stryker Corporation
Johnson&Johnson
Global Drug Eluting Sinus Stent (DESS) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Eluting Sinus Stent (DESS) market, Segment by Type:
Corticosteroid
Silicon Resin
Other
Global Drug Eluting Sinus Stent (DESS) market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Drug Eluting Sinus Stent (DESS) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Drug Eluting Sinus Stent (DESS) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Drug Eluting Sinus Stent (DESS) Market Overview
1.1 Drug Eluting Sinus Stent (DESS) Product Overview
1.2 Drug Eluting Sinus Stent (DESS) Market Segment by Type
1.2.1 Corticosteroid
1.2.2 Silicon Resin
1.2.3 Other
1.3 Global Drug Eluting Sinus Stent (DESS) Market Size by Type
1.3.1 Global Drug Eluting Sinus Stent (DESS) Market Size Overview by Type (2018-2029)
1.3.2 Global Drug Eluting Sinus Stent (DESS) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Drug Eluting Sinus Stent (DESS) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Drug Eluting Sinus Stent (DESS) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Drug Eluting Sinus Stent (DESS) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Drug Eluting Sinus Stent (DESS) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Drug Eluting Sinus Stent (DESS) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Drug Eluting Sinus Stent (DESS) Sales Breakdown by Type (2018-2023)
2 Global Drug Eluting Sinus Stent (DESS) Market Competition by Company
2.1 Global Top Players by Drug Eluting Sinus Stent (DESS) Sales (2018-2023)
2.2 Global Top Players by Drug Eluting Sinus Stent (DESS) Revenue (2018-2023)
2.3 Global Top Players by Drug Eluting Sinus Stent (DESS) Price (2018-2023)
2.4 Global Top Manufacturers Drug Eluting Sinus Stent (DESS) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Drug Eluting Sinus Stent (DESS) Market Competitive Situation and Trends
2.5.1 Drug Eluting Sinus Stent (DESS) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Drug Eluting Sinus Stent (DESS) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Eluting Sinus Stent (DESS) as of 2022)
2.7 Date of Key Manufacturers Enter into Drug Eluting Sinus Stent (DESS) Market
2.8 Key Manufacturers Drug Eluting Sinus Stent (DESS) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Drug Eluting Sinus Stent (DESS) Status and Outlook by Region
3.1 Global Drug Eluting Sinus Stent (DESS) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Drug Eluting Sinus Stent (DESS) Historic Market Size by Region
3.2.1 Global Drug Eluting Sinus Stent (DESS) Sales in Volume by Region (2018-2023)
3.2.2 Global Drug Eluting Sinus Stent (DESS) Sales in Value by Region (2018-2023)
3.2.3 Global Drug Eluting Sinus Stent (DESS) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Drug Eluting Sinus Stent (DESS) Forecasted Market Size by Region
3.3.1 Global Drug Eluting Sinus Stent (DESS) Sales in Volume by Region (2024-2029)
3.3.2 Global Drug Eluting Sinus Stent (DESS) Sales in Value by Region (2024-2029)
3.3.3 Global Drug Eluting Sinus Stent (DESS) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Drug Eluting Sinus Stent (DESS) by Application
4.1 Drug Eluting Sinus Stent (DESS) Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Drug Eluting Sinus Stent (DESS) Market Size by Application
4.2.1 Global Drug Eluting Sinus Stent (DESS) Market Size Overview by Application (2018-2029)
4.2.2 Global Drug Eluting Sinus Stent (DESS) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Drug Eluting Sinus Stent (DESS) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Drug Eluting Sinus Stent (DESS) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Drug Eluting Sinus Stent (DESS) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Drug Eluting Sinus Stent (DESS) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Drug Eluting Sinus Stent (DESS) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Drug Eluting Sinus Stent (DESS) Sales Breakdown by Application (2018-2023)
5 North America Drug Eluting Sinus Stent (DESS) by Country
5.1 North America Drug Eluting Sinus Stent (DESS) Historic Market Size by Country
5.1.1 North America Drug Eluting Sinus Stent (DESS) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Drug Eluting Sinus Stent (DESS) Sales in Volume by Country (2018-2023)
5.1.3 North America Drug Eluting Sinus Stent (DESS) Sales in Value by Country (2018-2023)
5.2 North America Drug Eluting Sinus Stent (DESS) Forecasted Market Size by Country
5.2.1 North America Drug Eluting Sinus Stent (DESS) Sales in Volume by Country (2024-2029)
5.2.2 North America Drug Eluting Sinus Stent (DESS) Sales in Value by Country (2024-2029)
6 Europe Drug Eluting Sinus Stent (DESS) by Country
6.1 Europe Drug Eluting Sinus Stent (DESS) Historic Market Size by Country
6.1.1 Europe Drug Eluting Sinus Stent (DESS) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Drug Eluting Sinus Stent (DESS) Sales in Volume by Country (2018-2023)
6.1.3 Europe Drug Eluting Sinus Stent (DESS) Sales in Value by Country (2018-2023)
6.2 Europe Drug Eluting Sinus Stent (DESS) Forecasted Market Size by Country
6.2.1 Europe Drug Eluting Sinus Stent (DESS) Sales in Volume by Country (2024-2029)
6.2.2 Europe Drug Eluting Sinus Stent (DESS) Sales in Value by Country (2024-2029)
7 Asia-Pacific Drug Eluting Sinus Stent (DESS) by Region
7.1 Asia-Pacific Drug Eluting Sinus Stent (DESS) Historic Market Size by Region
7.1.1 Asia-Pacific Drug Eluting Sinus Stent (DESS) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Drug Eluting Sinus Stent (DESS) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Drug Eluting Sinus Stent (DESS) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Drug Eluting Sinus Stent (DESS) Forecasted Market Size by Region
7.2.1 Asia-Pacific Drug Eluting Sinus Stent (DESS) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Drug Eluting Sinus Stent (DESS) Sales in Value by Region (2024-2029)
8 Latin America Drug Eluting Sinus Stent (DESS) by Country
8.1 Latin America Drug Eluting Sinus Stent (DESS) Historic Market Size by Country
8.1.1 Latin America Drug Eluting Sinus Stent (DESS) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Drug Eluting Sinus Stent (DESS) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Drug Eluting Sinus Stent (DESS) Sales in Value by Country (2018-2023)
8.2 Latin America Drug Eluting Sinus Stent (DESS) Forecasted Market Size by Country
8.2.1 Latin America Drug Eluting Sinus Stent (DESS) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Drug Eluting Sinus Stent (DESS) Sales in Value by Country (2024-2029)
9 Middle East and Africa Drug Eluting Sinus Stent (DESS) by Country
9.1 Middle East and Africa Drug Eluting Sinus Stent (DESS) Historic Market Size by Country
9.1.1 Middle East and Africa Drug Eluting Sinus Stent (DESS) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Drug Eluting Sinus Stent (DESS) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Drug Eluting Sinus Stent (DESS) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Drug Eluting Sinus Stent (DESS) Forecasted Market Size by Country
9.2.1 Middle East and Africa Drug Eluting Sinus Stent (DESS) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Drug Eluting Sinus Stent (DESS) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Intersect ENT,Inc.
10.1.1 Intersect ENT,Inc. Company Information
10.1.2 Intersect ENT,Inc. Introduction and Business Overview
10.1.3 Intersect ENT,Inc. Drug Eluting Sinus Stent (DESS) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Intersect ENT,Inc. Drug Eluting Sinus Stent (DESS) Products Offered
10.1.5 Intersect ENT,Inc. Recent Development
10.2 Medtronic Plc
10.2.1 Medtronic Plc Company Information
10.2.2 Medtronic Plc Introduction and Business Overview
10.2.3 Medtronic Plc Drug Eluting Sinus Stent (DESS) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medtronic Plc Drug Eluting Sinus Stent (DESS) Products Offered
10.2.5 Medtronic Plc Recent Development
10.3 Stryker Corporation
10.3.1 Stryker Corporation Company Information
10.3.2 Stryker Corporation Introduction and Business Overview
10.3.3 Stryker Corporation Drug Eluting Sinus Stent (DESS) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Stryker Corporation Drug Eluting Sinus Stent (DESS) Products Offered
10.3.5 Stryker Corporation Recent Development
10.4 Johnson&Johnson
10.4.1 Johnson&Johnson Company Information
10.4.2 Johnson&Johnson Introduction and Business Overview
10.4.3 Johnson&Johnson Drug Eluting Sinus Stent (DESS) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Johnson&Johnson Drug Eluting Sinus Stent (DESS) Products Offered
10.4.5 Johnson&Johnson Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Drug Eluting Sinus Stent (DESS) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Drug Eluting Sinus Stent (DESS) Industrial Chain Analysis
11.4 Drug Eluting Sinus Stent (DESS) Market Dynamics
11.4.1 Drug Eluting Sinus Stent (DESS) Industry Trends
11.4.2 Drug Eluting Sinus Stent (DESS) Market Drivers
11.4.3 Drug Eluting Sinus Stent (DESS) Market Challenges
11.4.4 Drug Eluting Sinus Stent (DESS) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Drug Eluting Sinus Stent (DESS) Distributors
12.3 Drug Eluting Sinus Stent (DESS) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’